Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
Admission vitamin D status is associated with discharge destination in critically ill surgical patients.

Annals of intensive care

Brook K, Camargo CA, Christopher KB, Quraishi SA.
PMID: 26380991
Ann Intensive Care. 2015 Dec;5(1):23. doi: 10.1186/s13613-015-0065-9. Epub 2015 Sep 17.

BACKGROUND: Discharge destination after critical illness is increasingly recognized as a valuable patient-centered outcome. Recently, vitamin D status has been shown to be associated with important outcomes such as length of stay (LOS) and mortality in intensive care unit...

Cite
Brook K, Camargo CA, Christopher KB, et al. Admission vitamin D status is associated with discharge destination in critically ill surgical patients. Ann Intensive Care. 2015;5(1):23doi: 10.1186/s13613-015-0065-9.
Brook, K., Camargo, C. A., Christopher, K. B., & Quraishi, S. A. (2015). Admission vitamin D status is associated with discharge destination in critically ill surgical patients. Annals of intensive care, 5(1), 23. https://doi.org/10.1186/s13613-015-0065-9
Brook, Karolina, et al. "Admission vitamin D status is associated with discharge destination in critically ill surgical patients." Annals of intensive care vol. 5,1 (2015): 23. doi: https://doi.org/10.1186/s13613-015-0065-9
Brook K, Camargo CA, Christopher KB, Quraishi SA. Admission vitamin D status is associated with discharge destination in critically ill surgical patients. Ann Intensive Care. 2015 Dec;5(1):23. doi: 10.1186/s13613-015-0065-9. Epub 2015 Sep 17. PMID: 26380991; PMCID: PMC4573737.
Copy Download .nbib Format: NLM
Addition of 25-hydroxyvitamin D levels to the Deyo-Charlson Comorbidity Index improves 90-day mortality prediction in critically ill patients.

Journal of intensive care

Mahato B, Otero TM, Holland CA, Giguere PT, Bajwa EK, Camargo CA, Quraishi SA.
PMID: 27330812
J Intensive Care. 2016 Jun 17;4:40. doi: 10.1186/s40560-016-0165-0. eCollection 2016.

BACKGROUND: The Deyo-Charlson Comorbidity Index (DCCI) has low predictive value in the intensive care unit (ICU). Our goal was to determine whether addition of 25-hydroxyvitamin D (25OHD) levels to the DCCI improved 90-day mortality prediction in critically ill patients.METHODS:...

Cite
Mahato B, Otero TM, Holland CA, et al. Addition of 25-hydroxyvitamin D levels to the Deyo-Charlson Comorbidity Index improves 90-day mortality prediction in critically ill patients. J Intensive Care. 2016;4:40doi: 10.1186/s40560-016-0165-0.
Mahato, B., Otero, T. M., Holland, C. A., Giguere, P. T., Bajwa, E. K., Camargo, C. A., & Quraishi, S. A. (2016). Addition of 25-hydroxyvitamin D levels to the Deyo-Charlson Comorbidity Index improves 90-day mortality prediction in critically ill patients. Journal of intensive care, 440. https://doi.org/10.1186/s40560-016-0165-0
Mahato, Bisundev, et al. "Addition of 25-hydroxyvitamin D levels to the Deyo-Charlson Comorbidity Index improves 90-day mortality prediction in critically ill patients." Journal of intensive care vol. 4 (2016): 40. doi: https://doi.org/10.1186/s40560-016-0165-0
Mahato B, Otero TM, Holland CA, Giguere PT, Bajwa EK, Camargo CA, Quraishi SA. Addition of 25-hydroxyvitamin D levels to the Deyo-Charlson Comorbidity Index improves 90-day mortality prediction in critically ill patients. J Intensive Care. 2016 Jun 17;4:40. doi: 10.1186/s40560-016-0165-0. eCollection 2016. PMID: 27330812; PMCID: PMC4912797.
Copy Download .nbib Format: NLM
Association of endemic coronaviruses with nasopharyngeal metabolome and microbiota among infants with severe bronchiolitis: a prospective multicenter study.

Pediatric research

Fujiogi M, Camargo CA, Raita Y, Toivonen L, Freishtat RJ, Mansbach JM, Piedra PA, Hasegawa K.
PMID: 32937650
Pediatr Res. 2021 May;89(7):1594-1597. doi: 10.1038/s41390-020-01154-2. Epub 2020 Sep 16.

No abstract available.

Cite
Fujiogi M, Camargo CA, Raita Y, et al. Association of endemic coronaviruses with nasopharyngeal metabolome and microbiota among infants with severe bronchiolitis: a prospective multicenter study. Pediatr Res. 2020;89(7):1594-1597doi: 10.1038/s41390-020-01154-2.
Fujiogi, M., Camargo, C. A., Raita, Y., Toivonen, L., Freishtat, R. J., Mansbach, J. M., Piedra, P. A., & Hasegawa, K. (2021). Association of endemic coronaviruses with nasopharyngeal metabolome and microbiota among infants with severe bronchiolitis: a prospective multicenter study. Pediatric research, 89(7), 1594-1597. https://doi.org/10.1038/s41390-020-01154-2
Fujiogi, Michimasa, et al. "Association of endemic coronaviruses with nasopharyngeal metabolome and microbiota among infants with severe bronchiolitis: a prospective multicenter study." Pediatric research vol. 89,7 (2021): 1594-1597. doi: https://doi.org/10.1038/s41390-020-01154-2
Fujiogi M, Camargo CA, Raita Y, Toivonen L, Freishtat RJ, Mansbach JM, Piedra PA, Hasegawa K. Association of endemic coronaviruses with nasopharyngeal metabolome and microbiota among infants with severe bronchiolitis: a prospective multicenter study. Pediatr Res. 2021 May;89(7):1594-1597. doi: 10.1038/s41390-020-01154-2. Epub 2020 Sep 16. PMID: 32937650; PMCID: PMC7960557.
Copy Download .nbib Format: NLM
Vitamin D and Major Chronic Illness.

Journal of restorative medicine

Quraishi SA, Camargo CA.
PMID: 30197839
J Restor Med. 2012 Sep;1(1):9-23. doi: 10.14200/jrm.2012.1.1001.

OBJECTIVE: To review the current literature regarding vitamin D insufficiency and supplementation in major illnesses.DESIGN AND METHODS: We reviewed Pubmed-indexed, English language manuscripts from January, 2003 to June, 2012 using search terms related to vitamin D, all-cause mortality, cardiovascular...

Cite
Quraishi SA, Camargo CA. Vitamin D and Major Chronic Illness. J Restor Med. 2012;1(1):9-23doi: 10.14200/jrm.2012.1.1001.
Quraishi, S. A., & Camargo, C. A. (2012). Vitamin D and Major Chronic Illness. Journal of restorative medicine, 1(1), 9-23. https://doi.org/10.14200/jrm.2012.1.1001
Quraishi, Sadeq A, and Camargo, Carlos A. "Vitamin D and Major Chronic Illness." Journal of restorative medicine vol. 1,1 (2012): 9-23. doi: https://doi.org/10.14200/jrm.2012.1.1001
Quraishi SA, Camargo CA. Vitamin D and Major Chronic Illness. J Restor Med. 2012 Sep;1(1):9-23. doi: 10.14200/jrm.2012.1.1001. PMID: 30197839; PMCID: PMC6128298.
Copy Download .nbib Format: NLM
Multicenter Observational Study of the Use of Nebulized Hypertonic Saline to Treat Children Hospitalized for Bronchiolitis From 2008 to 2014.

Hospital pediatrics

Davis J, Thompson AD, Mansbach JM, Piedra PA, Kasagawa K, Sullivan AF, Espinola JA, Camargo CA.
PMID: 28761004
Hosp Pediatr. 2017 Jul 31; doi: 10.1542/hpeds.2017-0002. Epub 2017 Jul 31.

OBJECTIVES: Among children hospitalized for bronchiolitis, we examined temporal trends in the use of hypertonic saline (HTS) and the characteristics associated with receiving this treatment.METHODS: We conducted a secondary analysis of data from 2 large, multicenter prospective cohort studies...

Cite
Davis J, Thompson AD, Mansbach JM, et al. Multicenter Observational Study of the Use of Nebulized Hypertonic Saline to Treat Children Hospitalized for Bronchiolitis From 2008 to 2014. Hosp Pediatr. 2017;doi: 10.1542/hpeds.2017-0002.
Davis, J., Thompson, A. D., Mansbach, J. M., Piedra, P. A., Kasagawa, K., Sullivan, A. F., Espinola, J. A., & Camargo, C. A. (2017). Multicenter Observational Study of the Use of Nebulized Hypertonic Saline to Treat Children Hospitalized for Bronchiolitis From 2008 to 2014. Hospital pediatrics, . https://doi.org/10.1542/hpeds.2017-0002
Davis, Joshua, et al. "Multicenter Observational Study of the Use of Nebulized Hypertonic Saline to Treat Children Hospitalized for Bronchiolitis From 2008 to 2014." Hospital pediatrics vol. (2017). doi: https://doi.org/10.1542/hpeds.2017-0002
Davis J, Thompson AD, Mansbach JM, Piedra PA, Kasagawa K, Sullivan AF, Espinola JA, Camargo CA. Multicenter Observational Study of the Use of Nebulized Hypertonic Saline to Treat Children Hospitalized for Bronchiolitis From 2008 to 2014. Hosp Pediatr. 2017 Jul 31; doi: 10.1542/hpeds.2017-0002. Epub 2017 Jul 31. PMID: 28761004; PMCID: PMC5525378.
Copy Download .nbib Format: NLM
Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma.

The Journal of allergy and clinical immunology

Zhu Z, Camargo CA, Raita Y, Fujiogi M, Liang L, Rhee EP, Woodruff PG, Hasegawa K.
PMID: 34119532
J Allergy Clin Immunol. 2022 Jan;149(1):102-112. doi: 10.1016/j.jaci.2021.05.036. Epub 2021 Jun 10.

BACKGROUND: Infants with bronchiolitis are at increased risk for developing asthma. Growing evidence suggests bronchiolitis is a heterogeneous condition.OBJECTIVES: We sought to identify biologically distinct subgroups based on the metabolome signatures (metabotypes) in infants with severe bronchiolitis and to...

Cite
Zhu Z, Camargo CA, Raita Y, et al. Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma. J Allergy Clin Immunol. 2021;149(1):102-112doi: 10.1016/j.jaci.2021.05.036.
Zhu, Z., Camargo, C. A., Raita, Y., Fujiogi, M., Liang, L., Rhee, E. P., Woodruff, P. G., & Hasegawa, K. (2022). Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma. The Journal of allergy and clinical immunology, 149(1), 102-112. https://doi.org/10.1016/j.jaci.2021.05.036
Zhu, Zhaozhong, et al. "Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma." The Journal of allergy and clinical immunology vol. 149,1 (2022): 102-112. doi: https://doi.org/10.1016/j.jaci.2021.05.036
Zhu Z, Camargo CA, Raita Y, Fujiogi M, Liang L, Rhee EP, Woodruff PG, Hasegawa K. Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma. J Allergy Clin Immunol. 2022 Jan;149(1):102-112. doi: 10.1016/j.jaci.2021.05.036. Epub 2021 Jun 10. PMID: 34119532; PMCID: PMC8660920.
Copy Download .nbib Format: NLM
Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma.

The Journal of allergy and clinical immunology

Zhu Z, Camargo CA, Raita Y, Fujiogi M, Liang L, Rhee EP, Woodruff PG, Hasegawa K.
PMID: 34119532
J Allergy Clin Immunol. 2022 Jan;149(1):102-112. doi: 10.1016/j.jaci.2021.05.036. Epub 2021 Jun 10.

BACKGROUND: Infants with bronchiolitis are at increased risk for developing asthma. Growing evidence suggests bronchiolitis is a heterogeneous condition.OBJECTIVES: We sought to identify biologically distinct subgroups based on the metabolome signatures (metabotypes) in infants with severe bronchiolitis and to...

Cite
Zhu Z, Camargo CA, Raita Y, et al. Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma. J Allergy Clin Immunol. 2021;149(1):102-112doi: 10.1016/j.jaci.2021.05.036.
Zhu, Z., Camargo, C. A., Raita, Y., Fujiogi, M., Liang, L., Rhee, E. P., Woodruff, P. G., & Hasegawa, K. (2022). Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma. The Journal of allergy and clinical immunology, 149(1), 102-112. https://doi.org/10.1016/j.jaci.2021.05.036
Zhu, Zhaozhong, et al. "Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma." The Journal of allergy and clinical immunology vol. 149,1 (2022): 102-112. doi: https://doi.org/10.1016/j.jaci.2021.05.036
Zhu Z, Camargo CA, Raita Y, Fujiogi M, Liang L, Rhee EP, Woodruff PG, Hasegawa K. Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma. J Allergy Clin Immunol. 2022 Jan;149(1):102-112. doi: 10.1016/j.jaci.2021.05.036. Epub 2021 Jun 10. PMID: 34119532; PMCID: PMC8660920.
Copy Download .nbib Format: NLM
Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma.

The Journal of allergy and clinical immunology

Zhu Z, Camargo CA, Raita Y, Fujiogi M, Liang L, Rhee EP, Woodruff PG, Hasegawa K.
PMID: 34119532
J Allergy Clin Immunol. 2022 Jan;149(1):102-112. doi: 10.1016/j.jaci.2021.05.036. Epub 2021 Jun 10.

BACKGROUND: Infants with bronchiolitis are at increased risk for developing asthma. Growing evidence suggests bronchiolitis is a heterogeneous condition.OBJECTIVES: We sought to identify biologically distinct subgroups based on the metabolome signatures (metabotypes) in infants with severe bronchiolitis and to...

Cite
Zhu Z, Camargo CA, Raita Y, et al. Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma. J Allergy Clin Immunol. 2021;149(1):102-112doi: 10.1016/j.jaci.2021.05.036.
Zhu, Z., Camargo, C. A., Raita, Y., Fujiogi, M., Liang, L., Rhee, E. P., Woodruff, P. G., & Hasegawa, K. (2022). Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma. The Journal of allergy and clinical immunology, 149(1), 102-112. https://doi.org/10.1016/j.jaci.2021.05.036
Zhu, Zhaozhong, et al. "Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma." The Journal of allergy and clinical immunology vol. 149,1 (2022): 102-112. doi: https://doi.org/10.1016/j.jaci.2021.05.036
Zhu Z, Camargo CA, Raita Y, Fujiogi M, Liang L, Rhee EP, Woodruff PG, Hasegawa K. Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma. J Allergy Clin Immunol. 2022 Jan;149(1):102-112. doi: 10.1016/j.jaci.2021.05.036. Epub 2021 Jun 10. PMID: 34119532; PMCID: PMC8660920.
Copy Download .nbib Format: NLM
Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma.

The Journal of allergy and clinical immunology

Zhu Z, Camargo CA, Raita Y, Fujiogi M, Liang L, Rhee EP, Woodruff PG, Hasegawa K.
PMID: 34119532
J Allergy Clin Immunol. 2021 Jun 10; doi: 10.1016/j.jaci.2021.05.036. Epub 2021 Jun 10.

BACKGROUND: Infants with bronchiolitis are at increased risk for developing asthma. Growing evidence suggests bronchiolitis is a heterogeneous condition.OBJECTIVES: We sought to identify biologically distinct subgroups based on the metabolome signatures (metabotypes) in infants with severe bronchiolitis and to...

Cite
Zhu Z, Camargo CA, Raita Y, et al. Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma. J Allergy Clin Immunol. 2021;doi: 10.1016/j.jaci.2021.05.036.
Zhu, Z., Camargo, C. A., Raita, Y., Fujiogi, M., Liang, L., Rhee, E. P., Woodruff, P. G., & Hasegawa, K. (2021). Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma. The Journal of allergy and clinical immunology, . https://doi.org/10.1016/j.jaci.2021.05.036
Zhu, Zhaozhong, et al. "Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma." The Journal of allergy and clinical immunology vol. (2021). doi: https://doi.org/10.1016/j.jaci.2021.05.036
Zhu Z, Camargo CA, Raita Y, Fujiogi M, Liang L, Rhee EP, Woodruff PG, Hasegawa K. Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma. J Allergy Clin Immunol. 2021 Jun 10; doi: 10.1016/j.jaci.2021.05.036. Epub 2021 Jun 10. PMID: 34119532; PMCID: PMC8660920.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries